Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 373,700 shares, an increase of 27.7% from the March 31st total of 292,600 shares. Based on an average daily volume of 86,400 shares, the days-to-cover ratio […]
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 26,545 shares of the business’s stock in a transaction on Friday, April 12th. The shares were sold at an average price of $0.86, for a total value of $22,828.70. Following the completion of the sale, the chief executive officer now owns 129,726 shares […]
Accelerate Diagnostics Announces 510 Submission of the Accelerate Arc™ System to the FDA Apr 09, 2024 Enabling rapid, automated microbial identification.
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 15,887 shares of the stock in a transaction dated Thursday, April 4th. The stock was sold at an average price of $0.88, for a total transaction of $13,980.56. Following the transaction, the chief executive officer now owns 96,343 shares of the company’s stock, […]
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) CEO Jack Phillips sold 15,887 shares of the stock in a transaction that occurred on Thursday, April 4th. The shares were sold at an average price of $0.88, for a total transaction of $13,980.56. Following the transaction, the chief executive officer now directly owns 96,343 shares of […]